Mounjaro

Zepbound, Mounjaro shortages are resolved, FDA confirms
BioPharma Dive
Thu, 12/19/24 - 09:36 pm
FDA
Eli Lilly
Zepbound
Mounjaro
drug shortages
UK's private obesity drug market chooses Lilly's Mounjaro over Wegovy
Yahoo/Reuters
Fri, 12/13/24 - 11:43 am
Eli Lilly
Mounjaro
Novo Nordisk
Wegovy
UK
obesity
For first phase of Mounjaro's obesity rollout in England, only a limited number of patients will have access
Fierce Pharma
Wed, 12/4/24 - 11:05 pm
Eli Lilly
Mounjaro
obesity
England
Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight
Xtalks
Fri, 11/15/24 - 11:27 am
Omada Health
GLP-1 agonists
obesity
weight loss
Novo Nordisk
Eli Lilly
Ozempic
Zepbound
Mounjaro
Wegovy
Eli Lilly’s weight-loss drug helps nearly 99% of patients remain diabetes-free
Pharma Live
Thu, 11/14/24 - 11:21 am
Eli Lilly
weight loss
tirzepatide
Mounjaro
Zepbound
diabetes
FDA adds aspiration warning to Ozempic, Mounjaro and other GLP-1 labels
Beckers Hospital Review
Wed, 11/6/24 - 08:01 pm
FDA
warnings
aspiration
Ozempic
Wegovy
Saxenda
Mounjaro
Novo Nordisk
Eli Lilly
Lilly shares fall as obesity drug sales miss forecasts
BioPharma Dive
Wed, 10/30/24 - 11:52 am
Eli Lilly
earnings
obesity
Zepbound
Mounjaro
Lilly to launch its obesity drug in Denmark, Novo Nordisk's home market
Reuters
Thu, 10/24/24 - 09:53 am
Eli Lilly
Mounjaro
Novo Nordisk
Denmark
obesity
FDA, facing pressure, to review position on Zepbound, Mounjaro shortage
BioPharma Dive
Mon, 10/14/24 - 11:17 pm
Eli Lilly
drug shortages
Zebound
Mounjaro
FDA
Lilly's weight-loss drug removed from FDA's shortage list
Reuters
Thu, 10/3/24 - 10:06 am
Eli Lilly
FDA
drug shortages
Mounjaro
Weight Loss From GLP-1 Drugs Not As Robust In Real-World Settings
Forbes
Wed, 10/2/24 - 11:20 am
weight loss
obesity
GLP-1 agonist
Ozempic
Wegovy
Novo Nordisk
Zepbound
Mounjaro
Eli Lilly
Patients sue over alleged stomach paralysis linked to Ozempic, Mounjaro
Beckers Hospital Review
Tue, 10/1/24 - 10:45 am
legal
Novo Nordisk
Eli Lilly
Ozempic
Mounjaro
gastroparesis
Inside the GLP-1 'price war'
Beckers Hospital Review
Tue, 09/24/24 - 11:52 am
GLP-1 agonists
obesity
weight loss
Eli Lilly
Novo Nordisk
Ozempic
Wegovy
Zepbound
Mounjaro
drug pricing
New research could ease concerns over suicide risk of obesity drugs
BioPharma Dive
Tue, 09/3/24 - 05:58 pm
obesity
suicide
GLP-1
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
Zepbound
Lilly’s tirzepatide cuts diabetes risk, study data show
BioPharma Dive
Tue, 08/20/24 - 11:54 am
Eli Lilly
tirzepatide
Mounjaro
Zepbound
type 2 diabetes
diabetes
clinical trials
FDA says all doses of Lilly's weight-loss and diabetes drug are now available
Reuters
Sun, 08/4/24 - 06:44 pm
Eli Lilly
FDA
Zepbound
Mounjaro
drug shortages
Patients on weight-loss drugs should inform doctor before surgery, EU regulator says
Reuters
Fri, 07/12/24 - 11:16 am
EMA
Novo Nordisk
Ozempic
Wegovy
Eli Lilly
Mounjaro
Zepbound
surgery
Lilly’s Mounjaro Helps Patients Lose More Weight Than Novo’s Ozempic: Study
BioSpace
Tue, 07/9/24 - 11:51 am
Eli Lilly
Mounjaro
Novo Nordisk
Ozempic
weight loss
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
Reuters
Mon, 07/1/24 - 09:52 pm
Eli Lilly
Mounjaro
India
obesity
Lilly files more lawsuits to curb sales of counterfeit Mounjaro
Reuters
Thu, 06/20/24 - 11:26 am
Eli Lilly
drug counterfeiting
Mounjaro

Pages